ACM Central Laboratory Expands its Business Development Team
ACM Central Laboratory, a central lab specializing in safety and specialty testing for clinical trials, announced expansion of its business development team by more than 100%.
Rochester, New York -- April 4, 2005 -- ACM Central Laboratory, a central lab specializing in safety and specialty testing for clinical trials, announced expansion of its business development team by more than 100%. Overwhelming demand for ACM Central Laboratory Services by new and existing customers has led to this growth.
ACM Central Laboratory Services has added U.S. business development directors in the Northeast, Southeast and on the West Coast. Tim Robey, Scott Keddy, Tab Moore and James Naumann join ACM's team of talented professionals. Highly experienced, these directors bring extensive knowledge of the clinical development industry. Their experience includes operational, clinical and business development responsibilities within contract research organizations (CRO), central labs, and pharmaceutical and biotech companies. In addition to sales in their respective regions, the directors will be responsible for ongoing client communication and ensuring customer satisfaction.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.
